{
  "cik": 1674632,
  "cik_padded": "0001674632",
  "entityName": "Beta Bionics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-067065",
      "filed": "2026-02-24",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 5297000.0,
        "cash": 31576000.0,
        "cost_of_revenue": 44714000.0,
        "eps_diluted": -1.81,
        "free_cash_flow": -56222000.0,
        "gross_profit": 55537000.0,
        "net_income": -73200000.0,
        "operating_cash_flow": -50925000.0,
        "operating_income": -71681000.0,
        "revenue": 100251000.0,
        "stockholders_equity": 287610000.0,
        "total_assets": 328743000.0,
        "total_liabilities": 41133000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.55397951142632,
        "leverage": 0.14301658495879838,
        "net_margin": -0.7301672801268815,
        "operating_margin": -0.7150153115679643,
        "revenue_growth_yoy": 0.5393864013266998,
        "roa_avg2y": -0.3060277431708153,
        "roa_period_end": -0.2226663381425612,
        "roe_avg2y": -3.4650887573964497,
        "roe_period_end": -0.25451131740899136
      }
    },
    {
      "accn": "0001193125-26-067065",
      "filed": "2026-02-24",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3395000.0,
        "cash": 30432000.0,
        "cost_of_revenue": 29236000.0,
        "eps_diluted": -8.6,
        "free_cash_flow": -51668000.0,
        "gross_profit": 35888000.0,
        "net_income": -54756000.0,
        "operating_cash_flow": -48273000.0,
        "operating_income": -45251000.0,
        "revenue": 65124000.0,
        "stockholders_equity": -245360000.0,
        "total_assets": 149645000.0,
        "total_liabilities": 73632000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.5510718014863952,
        "net_margin": -0.8407960199004976,
        "operating_margin": -0.6948436828204656,
        "revenue_growth_yoy": 4.429262192580242,
        "roa_avg2y": -0.4217109189980168,
        "roa_period_end": -0.365905977480036,
        "roe_avg2y": 0.24419296935100843
      }
    },
    {
      "accn": "0001193125-26-067065",
      "filed": "2026-02-24",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 402000.0,
        "cash": 26566000.0,
        "cost_of_revenue": 5687000.0,
        "eps_diluted": -8.31,
        "free_cash_flow": -32847000.0,
        "gross_profit": 6308000.0,
        "net_income": -44099000.0,
        "operating_cash_flow": -32445000.0,
        "operating_income": -35850000.0,
        "revenue": 11995000.0,
        "stockholders_equity": -203105000.0,
        "total_assets": 110040000.0,
        "total_liabilities": 51432000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.52588578574406,
        "roa_period_end": -0.4007542711741185,
        "roe_avg2y": 0.23636768067663794
      }
    },
    {
      "accn": "0000950170-25-046762",
      "filed": "2025-03-28",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -170034000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-067065",
    "filed": "2026-02-24",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3841",
  "sic_description": "Surgical & Medical Instruments & Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001674632.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001674632.json"
  },
  "ticker": "BBNX"
}